title: How to optimize the sequential use of novel therapeutics in metastatic prostate cancer patients? Response should be found in prostate cancer tissue.
authors.affiliation: Medical Oncology Unit, Policlinico Umberto I Hospital, University of Rome, Rome, Italy.
authors.forename: Edoardo
authors.initials: E
authors.lastname: Francini
authors.forename: Giandomenico
authors.initials: G
authors.lastname: Roviello
mesh_terms: D000737:Androstenols / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010669:Phenylthiohydantoin / Q000031:analogs & derivatives*; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy*; D043823:Taxoids / Q000627:therapeutic use*
chemical_list: D000737:Androstenols; D000970:Antineoplastic Agents; D043823:Taxoids; D010669:Phenylthiohydantoin